Enhanced expression of CKS1B in a number of cancers such as myeloma, breast cancer, lymphoma, renal carcinoma, ovarian cancer, salivary, and oesophageal cancers etc. has been associated with poor prognosis. This evidence concerns the gene CKS1B and ovarian cancer.